Monoferric Patient Solutions® Program

Here to help you with your Monoferric injection treatment needs

When you are enrolled in the Monoferric Patient Solutions® Program, you will have access to tools that will support your IDA treatment journey.

2 ways to enroll in the program

Call us at 1-800-992-9022
Monday to Friday, from 8 am to 8 pm ET (except holidays)

Download the Patient Solutions Program Enrollment Form and complete with your doctor

Financial support to help you gain access to Monoferric

Pharmacosmos Therapeutics is committed to helping ensure Monoferric is available and affordable, so you can just focus on your treatment journey.

Monoferric Patient Solutions Copay Assistance Program

Pay as little as $0 per dosea

The program allows patients to save on the cost of Monoferric throughout treatment.

See full Terms and Conditions.

Download the Copay Assistance Program Flashcard

The Monoferric Patient Solutions Patient Assistance Program

If you do not have insurance or insurance will not cover treatment, the Monoferric Patient Solutions Program is here to assist.

To be eligible to participate in the Monoferric Patient Solutions Copay Assistance Program, you must:

  • Have commercial health insurance (i.e., health insurance offered through an employer; NOT Medicare, Medicare Advantage, Medicaid, TRICARE, or Veteran Affairs healthcare)
  • Reside in the United States or Puerto Rico
  • Be treated by a healthcare professional in the United States or Puerto Rico
  • Be 18 years of age or older
  • Be prescribed Monoferric for an on-label diagnosis

If you’re eligible to participate:

  • You will receive savings of up to $2,000 per dose on out-of-pocket (OOP) expenses for Monoferrica
  • Copay assistance may be applied retroactively to Monoferric costs providing you have met all of the eligibility criteria at the time of your infusion

To be eligible to receive patient assistance, you must:

  • Fall within the income guidelineb
  • Be uninsured or underinsured (patients with claims covered, paid or reimbursed, in whole or in part, by Medicaid, Medicare, or other federal or state healthcare programs are not eligible for this program)
  • Be 18 years or older
  • Be prescribed Monoferric for an on‑label diagnosis
  • Reside in the United States or Puerto Rico
Previous
Resources
a If IDA returns within the coverage period, you would receive an annual maximum savings on OOP expenses of up to $4,000. Additional restrictions apply. Please see Full Terms and Conditions.
b Total household income is at or below 300% of the federal poverty level (FPL). Visit https://aspe.hhs.gov/poverty-guidelines, which lists the current FPL guidelines. Pharmacosmos Therapeutics Inc. and its authorized third-party agents will use the patient’s date of birth or social security number and/or additional demographic information as needed to access credit information and information derived from public and other sources to estimate income in conjunction with the eligibility determination process. As a soft credit inquiry, this option will not impact credit scores. Pharmacosmos Therapeutics Inc. and its authorized third-party agents reserve the right to ask for additional documents and information at any time. Note: Patients may retroactively qualify for assistance under the Patient Assistance Program if the patient’s healthcare provider submits an explanation of benefits (EOB) statement from the patient’s commercial insurance provider within 120 days of the date of service.​​

IMPORTANT SAFETY INFORMATION

Monoferric is contraindicated in patients with a history of serious hypersensitivity to Monoferric or any of its components. Reactions have included shock, clinically significant hypotension, loss of consciousness, and/or collapse.

What is Monoferric?

Monoferric (ferric derisomaltose) is a prescription iron treatment given through a vein (IV) to treat iron deficiency anemia in adults who:

  • cannot tolerate oral iron or who have not responded well to treatment with oral iron
  • have non-dialysis dependent chronic kidney disease

IMPORTANT SAFETY INFORMATION

Who should not receive Monoferric?

Do not receive Monoferric if you have had serious allergic reactions to ferric derisomaltose or any of its ingredients.

What are the possible side effects of Monoferric?

Monoferric may cause serious side effects, including:

  • Allergic (hypersensitivity) reactions. Serious life-threatening allergic reactions have happened in people who receive Monoferric. Symptoms of an allergic reaction including rash, itching, hives, dizziness, lightheadedness, breathing problems, and low blood pressure have also happened during treatment with Monoferric. Tell your healthcare provider right away if you develop any of the above symptoms of a serious allergic reaction or if you have ever had any unusual or allergic reaction to any IV iron in the past.
  • Too much iron stored in your body (iron overload). Your healthcare provider should check the iron level in your blood before you start and during treatment with Monoferric.

The most common side effects of Monoferric include rash and nausea.

These are not all the possible side effects of Monoferric. Call your doctor for medical advice about side effects.

What should I tell my doctor or healthcare provider before receiving Monoferric?

Before receiving Monoferric, tell your healthcare provider about all your medical conditions, including if you:

  • have had an allergic reaction to IV iron.
  • are pregnant or plan to become pregnant. It is not known if Monoferric will harm your unborn baby. Untreated iron deficiency anemia during pregnancy may increase risks for you and your baby.
  • are breastfeeding or plan to breastfeed. Data from women treated with Monoferric show that iron is present in breast milk. It is not known how Monoferric may affect your breastfed baby.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see full Prescribing Information including information for patients.